Trial Profile
A trial to evaluate safety of sorafenib, in subject with hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 08 Mar 2016 New trial record